In our study, we utilized multiple bioinformatic datasets and analyzed 108 clinical samples to assess the expression of AMDHD1 in CCA, examining its correlation with clinicopathological characteristics and patient survival. The gene discussed is AMDHD1; the disease is cholangiocarcinoma.